Key Takeaways
Wolfe Research initiates coverage on ACADIA Pharmaceuticals with an ‘Outperform’ rating and a price target of $33.00 Recent analyst action
ACADIA Pharmaceuticals (ACAD) Receives New Analyst Coverage with ‘Outperform’ Rating
Feb 24, 2026
